← All trials
NCT04061421
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2019
- Primary completion
- Nov 30, 2023
- Completion date
- Nov 30, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 159
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vanderbilt UniversityLead sponsor
- Vanderbilt UniversityStudy chair
- Vanderbilt UniversitySponsor investigator
- IncyteCollaborator
- Astex Pharmaceuticals, Inc.Collaborator
- TheradexCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.